0001765581-19-000074.txt : 20190812
0001765581-19-000074.hdr.sgml : 20190812
20190812173247
ACCESSION NUMBER: 0001765581-19-000074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190808
FILED AS OF DATE: 20190812
DATE AS OF CHANGE: 20190812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RIEDEL NORBERT G
CENTRAL INDEX KEY: 0001161662
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33500
FILM NUMBER: 191017630
MAIL ADDRESS:
STREET 1: BAXTER INTERNATIONAL INC
STREET 2: ONE BAXTER PKWY DF2-1W
CITY: DEERFIELD
STATE: IL
ZIP: 60015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jazz Pharmaceuticals plc
CENTRAL INDEX KEY: 0001232524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981032470
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 353-1-634-7800
MAIL ADDRESS:
STREET 1: FIFTH FLOOR, WATERLOO EXCHANGE
STREET 2: WATERLOO ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: JAZZ PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030513
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2019-08-08
0
0001232524
Jazz Pharmaceuticals plc
JAZZ
0001161662
RIEDEL NORBERT G
5TH FL, WATERLOO EXCHANGE
WATERLOO RD
DUBLIN 4
L2
IRELAND
1
0
0
0
Ordinary Shares
2019-08-08
4
A
0
1920
0.0
A
8411
D
Ordinary Shares
2019-08-09
4
S
0
726
135.6497
D
7685
D
Non-Qualified Stock Option (right to buy)
137.12
2019-08-08
4
A
0
4805
0.0
A
2029-08-07
Ordinary Shares
4805
4805
D
These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 1, 2020.
Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.60 to $135.65. The price reported reflects the weighted
average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019.
By: /s/Peter A Christou, as attorney in fact For: Norbert G. Riedel
2019-08-12